Florence Joly
ScholarGPS® ID: 18706659758463
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Ovarian Cancer | Chemotherapy | Prostate Cancer | Breast Cancer | Renal Cell Carcinoma | Docetaxel | Neoplasm | Gynecologic Oncology | Bevacizumab | Cancer Survivor | Hormone | Nutrition | Clinical Nutrition | Paclitaxel
Metrics Summary
Publication Count
453
Predicted Citations
13,938
Predicted h-index
68
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis (journal article) Cancer, volume 130, issue 12, pages 2120-2138 (2024). |
Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA5505-LBA5505 (2024). |
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study (journal article) Breast Cancer Research, volume 26, issue 1 (2024). |
Frontiers in Oncology, volume 14 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5605-5605 (2024). |
Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer (journal article) Gynecologic Oncology, volume 185 (2024). |
Digital cognitive stimulation in elderly breast cancer patients: the Cog-Tab-Age feasibility study (journal article) BMC Complementary Medicine and Therapies, volume 24, issue 1 (2024). |
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer (journal article) British Journal of Cancer, volume 130, issue 3, pages 425-433 (2024). |
Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 637-637 (2024). |
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial (journal article) Therapeutic Advances in Urology, volume 16 (2024). |
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study (journal article) Journal of Cancer Survivorship (2023). |
Frontiers in Pharmacology, volume 14 (2023). |
Does COVID ‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital (journal article) Cancer Medicine, volume 12, issue 17, pages 17603-17612 (2023). |
Journal of Clinical Oncology, volume 41, issue 17_suppl, pages LBA4507-LBA4507 (2023). |
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : Prise en charge du cancer de l'endomètre métastatique et/ou en rechute (journal article) Bulletin du Cancer, volume 110, issue 6, pages 6S34-6S43 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 5501-5501 (2023). |
Journal of Clinical Oncology, volume 41, issue 16_suppl, pages TPS5630-TPS5630 (2023). |
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy (journal article) Journal of the National Comprehensive Cancer Network, volume 21, issue 5, pages 473-479.e4 (2023). |
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse (journal article) International Journal of Gynecologic Cancer, volume 33, issue 4, pages 577-584 (2023). |
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment (journal article) Expert Review of Neurotherapeutics, volume 23, issue 3, pages 249-268 (2023). |